Alluvi Retatrutide 20mg — Research-Grade Triple Agonist Peptide

£100.00

High-purity Alluvi Retatrutide (20mg) formulated for controlled laboratory investigation. As an investigational GLP-1, GIP, and glucagon receptor agonist, each batch is independently verified for consistency and supplied exclusively for qualified non-clinical R&D applications.

Alluvi Retatrutide 20mg provides a verified, analytical-grade presentation of the investigational triple-agonist peptide for controlled laboratory and in-vitro study. Unlike single- or dual-target peptides, Retatrutide simultaneously engages three distinct signaling pathways:

  • GLP-1 Receptors: Glucagon-like peptide-1 pathway dynamics and metabolic signaling.

  • GIP Receptors: Glucose-dependent insulinotropic polypeptide receptor activity.

  • Glucagon Receptors: Glucagon pathway signaling and metabolic cross-talk.

This multi-receptor profile allows researchers to examine downstream interactions, binding kinetics, and signal transduction within a single compound.

Analytical Testing & Certificate of Analysis

Each kit is independently tested to ensure compound identity, strength, and analytical consistency. The accompanying third-party report by Janoshik reflects the following findings:

Parameter Laboratory Specification / Result
Testing Laboratory Janoshik Analytical
Task Number #163215
Verification Key GBHEFN58JXXZ
Batch Identifier AR1721TRT
Analysis Date 14 May 2026
Purity (Reported Values) 99.216% (Vial 1) / 99.768% (Vial 2)*
Measured Strength 9.57 mg/ml (Vial 1) / 9.22 mg/ml (Vial 2)

*Note: In the second vial, a peak with $\lambda_{\max}$ at 205, 218, and 257 nm was not counted among impurities in the source report. Results are reported verbatim without averaging. Confirm that batch AR1721TRT matches your vial before preparation.

Target Research Applications

  • In-vitro metabolic receptor interaction and cross-talk modeling

  • Signal transduction and comparative triple-agonist assays

  • Peptide stability, solubility, and formulation dynamics

  • Quantitative biochemical profiling and analytical methodology

Storage & Handling Protocol

  • Store refrigerated at 2°C to 8°C immediately upon receipt.

  • Shield from direct light, excessive heat, and repeated freeze-thaw cycles.

  • Maintain complete batch documentation in research records.

  • Handle using standard laboratory PPE and in accordance with institutional biosafety protocols.

UK Cold-Chain Delivery

  • Dispatched from Lancashire Peptides via tracked UK cold-chain transit.

  • Dispatches within 1–2 business days (Monday to Friday, excluding UK bank holidays).

  • Packed in plain, tamper-evident outer packaging.

  • Continuously cold-stored at 2°C to 8°C prior to fulfillment.

Research Use Only (RUO)

Laboratory Notice: This product is supplied strictly for in-vitro laboratory experimentation, scientific investigation, and non-clinical R&D. It is not an approved medicine, food, dietary supplement, or cosmetic, and is strictly prohibited for human or veterinary administration, clinical application, or therapeutic use.

Tablets

20

Reviews

There are no reviews yet.

Be the first to review “Alluvi Retatrutide 20mg — Research-Grade Triple Agonist Peptide”
Scroll to Top